Until very recently, understanding the complexity of the stem cell (SC) compartment in both normal and leukemic hematopoiesis has been challenging due to the inability to separate and study normal and leukemic SCs at the single-cell level. Recent advances in cell-sorting techniques and single-cell technologies now make this possible, with the identification of a population of highly quiescent chronic myeloid leukemia (CML) SCs that is enriched following therapy with tyrosine kinase inhibitors (TKIs).
Keywords: chronic myeloid leukemia; hematopoietic stem cell; heterogeneity; leukemic stem cell; single-cell transcriptomics.
Copyright © 2017 Elsevier Inc. All rights reserved.